BPC-157 dosage chart by weight doesn't exist in human data—here's what research actually shows, plus safety notes and why weight-based dosing is unproven.
There is no official BPC-157 dosage chart by weight for humans, and no validated human dose of this peptide exists. BPC-157 is not FDA-approved for human use in the United States, so any chart that scales milligrams to pounds or kilograms is built from animal data, forum consensus, or both. Those charts can help you understand what has been studied, but they are not medical guidance and they do not establish a safe or effective dose.
Why a Weight-Based BPC-157 Dosage Chart Doesn't Exist
BPC-157 is a synthetic 15-amino-acid peptide based on a fragment of human gastric juice protein. Researchers have studied it in rodents since the early 1990s, mostly in models of tendon injury, gut inflammation, and wound healing. Peer-reviewed human clinical trials are essentially absent from the literature.
Weight-based dosing only becomes possible after researchers establish a dose range in humans. That step never happened for BPC-157, so there is nothing to scale. A chart that claims otherwise is repackaging animal numbers or anecdotal reports.
- BPC-157 is not FDA-approved for any human indication.
- In 2023, the FDA placed bulk BPC-157 on its list of substances that may not be used in compounded drugs, citing safety concerns.
- WADA classifies BPC-157 as a prohibited substance for athletes.
- Products sold online typically carry a research-use-only label, meaning they are not intended for human consumption.
What BPC-157 Doses Look Like in Animal Research
Rodent studies are the main source of dose information, and their numbers are small. A common protocol gives 10 micrograms per kilogram per day, with higher ranges appearing in some papers. The table below summarizes doses that show up repeatedly in published animal work.
| Species / model | Reported study dose | Common route | Context |
|---|---|---|---|
| Rat | 10 µg/kg per day | Intraperitoneal | Most frequently cited dose in tendon and GI models |
| Rat | 10–100 µg/kg per day | Subcutaneous or intraperitoneal | Wound healing and vascular studies |
| Rat | Up to 1 mg/kg per day | Oral or intraperitoneal | Upper end of published ranges |
| Mouse | About 10–100 µg/kg | Intraperitoneal | Smaller studies using a similar scale |
The gap between these numbers and what people discuss online is enormous. A 250-gram rat given 10 µg/kg receives roughly 2.5 micrograms in total, while community reports often describe 250 to 500 micrograms per day for an adult. Those are different orders of magnitude, and nothing in the literature bridges them.
The Problem With Scaling Animal Doses to Human Body Weight
Simply multiplying an animal dose by human weight ignores how differently species absorb, distribute, and clear peptides. If you took the most common rodent figure of 10 µg/kg and applied it directly to a 70 kg adult, you would get 700 micrograms. That number has never been validated in a human trial.
Allometric scaling, which adjusts for body surface area and metabolic rate, is a standard tool in drug development. It is used to pick starting doses for early safety studies, not to justify a dose that people should copy at home.
When someone searches for bpc-157 dosage per body weight, they usually find a mix of rat data, bodybuilding forum posts, and vendor blogs. None of those sources carries clinical authority.
Weight Is Not the Only Variable: Route and Goal Matter More
Route of administration changes everything about how a peptide behaves. Injections bypass digestion, while oral dosing exposes the peptide to stomach acid and enzymes. BPC-157 shows unusual stability in gastric juice under lab conditions, but that stability does not prove oral dosing works the same way as injection.
Discussions of bpc-157 dosage for gut health usually center on oral capsules, because that route reaches the intestinal tract directly. Injury-focused discussions usually assume subcutaneous injection. No head-to-head human study has compared the two approaches.
A frequent question, does bpc-157 help with muscle growth, has no answer from human trials either. Preclinical work has focused on tendon and ligament repair rather than muscle hypertrophy, and animal findings cannot be assumed to transfer to people.
| Route | How it appears in research | Human evidence |
|---|---|---|
| Subcutaneous injection | Frequent in rodent studies | No controlled human trials |
| Oral capsule or liquid | Used in GI and colitis models | No controlled human trials |
| Intranasal | Limited animal work | None published |
| Topical | Local wound models | None published |
Storage, Sourcing, and Quality Control
Instructions on how to store bpc 157 matter because peptides degrade quickly when handled poorly. Lyophilized powder generally stays stable in the refrigerator or freezer, protected from light, while a reconstituted solution is typically refrigerated and used within a few weeks. Repeated freeze-thaw cycles can damage the peptide.
People who ask where to buy bpc-157 peptide usually end up on research chemical websites. Quality varies widely, and a certificate of analysis is only as trustworthy as the lab behind it. Third-party testing and transparent batch documentation are the minimum you should expect.
Buying from overseas pharmacies or unregulated suppliers adds legal and safety risk. Products may be mislabeled, underdosed, or contaminated, and no regulatory body is checking any of it.
Safety, Legality, and a Sensible Next Step
Reported side effects from community use include injection-site irritation, nausea, and dizziness, but the lack of systematic human data means long-term risks are unknown. Anyone considering BPC-157 should speak with a licensed healthcare professional rather than rely on a weight-based chart.
If you are an athlete, check your sport's anti-doping rules before touching any peptide. A positive test for a prohibited substance can end a career, and a research-use-only label offers no protection.
The most defensible conclusion is simple: no BPC-157 dosage chart by weight has been validated for humans, and weight-based numbers circulating online should be read as speculation rather than instruction.
A final point on expectations: BPC-157 is often marketed alongside other peptides, and comparisons like bpc-157 vs cjc 1295 or blend products tend to blur the fact that none of these compounds has cleared the FDA approval process for human use. Marketing language is not evidence.
Frequently Asked Questions
Is there an official BPC-157 dosage chart by weight?
No. BPC-157 has never been tested in a controlled human trial that established a dose range, so there is no weight-based chart with clinical backing. The charts circulating online are built from rodent studies, forum reports, or vendor marketing.
How much BPC-157 do people typically report taking?
Community reports most often mention 250 to 500 micrograms per day, sometimes split into two smaller doses, with occasional higher amounts. These figures come from anecdotes rather than clinical trials, so they should not be treated as safe or effective. BPC-157 is not FDA-approved for human use.
Is BPC-157 legal to buy in the United States?
BPC-157 is not an approved drug, and the FDA has stated it may not be used in compounded medications because of safety concerns. It is widely sold as a research chemical labeled for laboratory use only. Buying it for personal human use sits in a legal gray area, and imported products can be seized.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.